Download Clinical approach to determination of the need for prophylaxis in

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Remote ischemic conditioning wikipedia , lookup

Cardiovascular disease wikipedia , lookup

Management of acute coronary syndrome wikipedia , lookup

Cardiac contractility modulation wikipedia , lookup

Saturated fat and cardiovascular disease wikipedia , lookup

Heart failure wikipedia , lookup

Electrocardiography wikipedia , lookup

Hypertrophic cardiomyopathy wikipedia , lookup

Antihypertensive drug wikipedia , lookup

Cardiothoracic surgery wikipedia , lookup

Jatene procedure wikipedia , lookup

Coronary artery disease wikipedia , lookup

Mitral insufficiency wikipedia , lookup

Lutembacher's syndrome wikipedia , lookup

Rheumatic fever wikipedia , lookup

Quantium Medical Cardiac Output wikipedia , lookup

Dextro-Transposition of the great arteries wikipedia , lookup

Infective endocarditis wikipedia , lookup

Transcript
When do you give prophylactic
treatment in MVP?
Clinical approach to determination of the need
for prophylaxis in patients with suspected MVP
Prevention of Bacterial Endocarditis: Recommendations by the American Heart
Association
• A reasonable approach for endocarditis
prophylaxis should consider the following:
– the degree to which the patient’s underlying condition
creates a risk of endocarditis
– the apparent risk of bacteremia with the procedure
– the potential adverse reactions of the prophylactic
antimicrobial agent to be used; and the cost-benefit
aspects of the recommended prophylactic regimen
Failure to consider all of these factors may lead to
overuse of antimicrobial agents, excessive cost, and
risk of adverse drug reactions
Prevention of Bacterial Endocarditis: Recommendations by the American Heart
Association
• Prophylaxis is recommended in individuals
who have a higher risk for developing
endocarditis than the general population and
is particularly important for individuals in
whom endocardial infection is associated with
high morbidity and mortality
Prevention of Bacterial Endocarditis: Recommendations by the American Heart
Association
Prevention of Bacterial Endocarditis: Recommendations by the American Heart
Association
Endocarditis prophylaxis
recommended
High-risk category
• Prosthetic cardiac valves
• Previous bacterial endocarditis
• Complex cyanotic congenital heart disease
Eg. Single ventricle states, Transposition of the
great arteries, Tetralogy of Fallot
• Surgically constructed systemic pulmonary shunts
or conduits
Prevention of Bacterial Endocarditis: Recommendations by the American Heart
Association
Moderate-risk category
• Acquired valvular dysfunction (eg, rheumatic
heart disease)
• Hypertrophic cardiomyopathy
• Mitral valve prolapse with valvular regurgitation
and/or thickened leaflets
Prevention of Bacterial Endocarditis: Recommendations by the American Heart
Association
Endocarditis prophylaxis NOT
recommended
Negligible-risk category
• Isolated secundum atrial septal defect
• Surgical repair of ASD, VSD or PDA
• Previous coronary artery bypass graft surgery
• Mitral valve prolapse without valvular regurgitation
• Physiologic, functional, or innocent heart murmurs
• Previous Kawasaki disease without valvular
dysfunction
• Previous rheumatic fever without valvular dysfunction
• Cardiac pacemakers and implanted defibrillators
Prevention of Bacterial Endocarditis: Recommendations by the American Heart
Association
Prophylaxis
• Prophylaxis at the time of cardiac surgery should be directed
primarily against staphylococci and should be of short
duration
• First-generation cephalosporins are most often used
• Prophylaxis is most effective when given perioperatively in
doses that are sufficient to assure adequate antibiotic
concentrations during and after the procedure
• Antibiotics should be used only during the perioperative
period - initiated shortly before a procedure and should not
be continued no more than 6 to 8 hours
• In the case of delayed healing, or of a procedure that involves
infected tissue, it may be necessary to provide additional
doses of antibiotics
Prophylaxis
Antimicrobial prophylaxis
administered within 2 hours
following the procedure will
provide effective prophylaxis
Prevention of Bacterial Endocarditis: Recommendations by the American Heart
Association
Streptococcus viridans is the most common
cause of endocarditis following:
– dental or oral procedures
– certain upper respiratory tract procedures
– bronchoscopy with a rigid bronchoscope
– surgical procedures that involve the respiratory
mucosa
– esophageal procedures
Prevention of Bacterial Endocarditis: Recommendations by the American Heart
Association
• The recommended standard prophylactic regimen for
all these procedures is a single dose of oral
amoxicillin to be administered 1 hour before the
anticipated procedure
– Adult dose is 2.0 g
– Pediatric dose is 50 mg/kg (not to exceed adult dose)
• For individuals who are unable to take or unable to
absorb oral medications, parenteral Ampicillin
sodium is recommended
Durack DT. Prevention of infective endocarditis. N Engl J Med. 1995
• Individuals who are allergic to penicillin
– Clindamycin hydrochloride
– Azithromycin or clarithromycin
• When parenteral administration is needed in an
individual who is allergic to penicillin, clindamycin
phosphate is recommended
Durack DT. Prevention of infective endocarditis. N Engl J Med. 1995
Prophylaxis
• Enterococcus faecalis is the most common
cause of bacterial endocarditis that occurs
following genitourinary and gastrointestinal
tract surgery or instrumentation
• Antibiotic prophylaxis should be directed
primarily against Enterococci
Prevention of Bacterial Endocarditis: Recommendations by the American Heart
Association
Prevention of Bacterial Endocarditis: Recommendations by the American Heart
Association
Prevention of Bacterial Endocarditis: Recommendations by the American Heart
Association
• High-risk patients
– Ampicillin plus gentamicin
• High-risk patients allergic to ampicillin/amoxicillin
– Vancomycin plus gentamicin
• Moderate-risk patients
– Amoxicillin or ampicillin
• Moderate-risk patients allergic to ampicillin/amoxicillin
– Vancomycin
Prevention of Bacterial Endocarditis: Recommendations by the American Heart
Association